p-ERK expression was significantly different in the tumors of patients with and without lymph node metastasis (P < 0.01, Chi-square test), which indicated that the expression of p-ERK1/2 correlates with metastasis and poorer prognosis in IBDC. The gene discussed is MAPK3; the disease is metastatic malignant neoplasm in the lymph nodes.